Literature DB >> 24844605

Telomerase, hTERT and splice variants in patients with myelodysplastic syndromes.

Wen Dong1, Yaqin Qian2, Lili Yang3.   

Abstract

Telomeres are specialized structures maintaining chromosome integrity during cellular division and preventing from premature senescence and apoptosis. The rate-limiting component of telomerase is human telomerase reverse transcriptase (hTERT), for which multiple transcripts exist. The aim of this work was to characterize hTERT splice variants in MDS and its relation to telomerase activity, telomere length and hTERT expression. The telomere length in PBMCs of patients with MDS cases was significantly shorter compared to controls (n=30, p=0.002). MDS patients had significantly higher basal telomerase activity (p=0.022) and higher total hTERT (p=0.007), α+β+ hTERT variant (p=0.016) and α+β- hTERT variant expression than control. The ratio of α+β- transcript to α+β+ transcript was significantly increased in cases (p=0.039). This study provided a detailed insight into the hTERT transcript pattern in MDS while correlation analysis showed that only telomerase activity was significantly correlated with total hTERT expression in MDS.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Homeostasis; Myelodysplastic syndrome; Senescence; Splice variant; Telomere

Mesh:

Substances:

Year:  2014        PMID: 24844605     DOI: 10.1016/j.leukres.2014.04.008

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  7 in total

1.  Imetelstat inhibits growth of megakaryocyte colony-forming units from patients with essential thrombocythemia.

Authors:  Gabriela M Baerlocher; Monika Haubitz; Thomas R Braschler; Claudio Brunold; Bart Burington; Elisabeth Oppliger Leibundgut; Ning Go
Journal:  Blood Adv       Date:  2019-11-26

Review 2.  Aberrant Splicing of Estrogen Receptor, HER2, and CD44 Genes in Breast Cancer.

Authors:  Kazushi Inoue; Elizabeth A Fry
Journal:  Genet Epigenet       Date:  2015-12-02

Review 3.  Significance of alternative splicing in cancer cells.

Authors:  Fei Qi; Yong Li; Xue Yang; Yan-Ping Wu; Lian-Jun Lin; Xin-Min Liu
Journal:  Chin Med J (Engl)       Date:  2020-01-20       Impact factor: 2.628

Review 4.  TERT-Regulation and Roles in Cancer Formation.

Authors:  Marta Dratwa; Barbara Wysoczańska; Piotr Łacina; Tomasz Kubik; Katarzyna Bogunia-Kubik
Journal:  Front Immunol       Date:  2020-11-19       Impact factor: 7.561

5.  Expression Pattern of Alternative Splicing Variants of Human Telomerase Reverse Transcriptase (hTERT) in Cancer Cell Lines Was not Associated with the Origin of the Cells.

Authors:  Mohsen Khosravi-Maharlooei; Mansooreh Jaberipour; Ahmad Hosseini Tashnizi; Armin Attar; Fatemeh Amirmoezi; Mojtaba Habibagahi
Journal:  Int J Mol Cell Med       Date:  2015

6.  MDS shows a higher expression of hTERT and alternative splice variants in unactivated T-cells.

Authors:  Wen Dong; Lei Wu; Houfang Sun; Xiubao Ren; Pearlie K Epling-Burnette; Lili Yang
Journal:  Oncotarget       Date:  2016-11-01

Review 7.  Alternative Splicing of Human Telomerase Reverse Transcriptase (hTERT) and Its Implications in Physiological and Pathological Processes.

Authors:  Anna A Plyasova; Dmitry D Zhdanov
Journal:  Biomedicines       Date:  2021-05-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.